Use access key #2 to skip to page content.
$14.77 1.18 (8.68%)
11/21/2008 4:00 PM

BioMarin Pharmaceutical, Inc. (BMRN)

CAPS Rating:
****

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

View All Commentary (BMRN)

Recs

0

Avatar jturano7423 (27.33) Submitted: 7/11/08 12:53 PM : Outperform Start Price: $26.61 BMRN Score: -6.26

selected this stock two years ago and still love its potential

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links